News Releases

Expert tips for preventing spring respiratory disease outbreaks RAHWAY, N.J., February 11, 2025 – As winter transitions to spring, horse owners and barn managers should be on alert for equine influenza (EIV), a highly contagious respiratory disease that has historically surged during this time of year (see figure 1). Recent biosurveillance data underscores this seasonal […]

Read more

Parasiticide Treatment for Dogs Offers Unrivaled Duration of Flea and Tick Protection Compared to Existing Products Rahway, N.J., February 11, 2025 – Merck Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that S&P Global Animal Health awarded the injectable formulation of BRAVECTO® (fluralaner) the 2024 Best New Companion […]

Read more

RAHWAY, N.J., Jan. 30, 2025 – Merck Animal Health, known as MSD Animal Health outside  of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that Laurie Hueneke Martens, associate vice president, Global Public Policy and Government Relations, was awarded the 8th Annual Feather in Her […]

Read more

The new formulation targets internal and external parasites, expanding the BRAVECTO® portfolio RAHWAY, N.J., November 26, 2024 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that the European Commission has granted the marketing authorization for […]

Read more

Vaccine can now be administered intramuscularly or through subcutaneous injection as well as at the same time as BOVILIS® CRYPTIUM® Subcutaneous injections are generally well-tolerated by animals, can minimize pain and distress, and improve meat quality[i] RAHWAY, N.J., October 15, 2024 – Merck Animal Health, known as MSD Animal Health outside of the United States […]

Read more

RAHWAY, N.J., September 28, 2024 – Merck Animal Health, known as MSD Animal Health outside  of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced it has donated more than six million NOBIVAC® rabies vaccines through the Company’s Afya Program, since it was founded. “Many communities where rabies […]

Read more

New vaccine protects against two of the most common swine diseases, while offering animal-friendly and efficient administration through IDAL® device technology Rahway, NJ, Sept. 25, 2024 – Merck Animal Health, known as MSD Animal Health outside  of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced […]

Read more